Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

Page

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 156

Gouty Arthritis (Gout) (Musculoskeletal) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Gouty Arthritis - Drugs In Development, 2021, provides an overview of the....

USD 2000 View Report

Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 33

Osteonecrosis (Musculoskeletal) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Drugs In Development, 2021, provides an overview of the Osteonecrosis (Musculoskeletal Disorders)....

USD 2000 View Report

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 86

Pigmented Villonodular Synovitis (Musculoskeletal) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Pigmented Villonodular Synovitis - Drugs In Development, 2021, provides an overview of....

USD 2000 View Report

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 137

Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Drugs In Development, 2021, provides an overview of the Dermatomyositis (Musculoskeletal Disorders)....

USD 2000 View Report

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021

By Global Markets Direct | Pharmaceuticals and Healthcare | Oct 2021 | Page 2145

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) (Oncology) - Drugs in Development, 2021 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia - Drugs In Development, 2021,....

USD 2500 View Report